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Abstract
It has previously been shown that expression of human papillomavirus type 16 (HPV) E7 in
epidermis causes hyperplasia and chronic inflammation, characteristics of pre-malignant le-
sions. Importantly, E7-expressing epidermis is strongly immune suppressed and is not re-
jected when transplanted onto immune competent mice. Professional antigen presenting
cells are considered essential for initiation of the adaptive immune response that results in
graft rejection. Langerhans cells (LC) are the only antigen presenting cells located in normal
epidermis and altered phenotype and function of these cells may contribute to the immune
suppressive microenvironment. Here, we show that LC are atypically activated as a direct
result of E7 expression in the epidermis, and independent of the presence of lymphocytes.
The number of LC was significantly increased and the LC are functionally impaired, both in
migration and in antigen uptake. However when the LC were extracted from K14E7 skin
and matured in vitro they were functionally competent to present and cross-present antigen,
and to activate T cells. The ability of the LC to present and cross-present antigen following
maturation supports retention of full functional capacity when removed from the hyperplastic
skin microenvironment. As such, opportunities are afforded for the development of thera-
pies to restore normal LC function in hyperplastic skin.
Introduction
Squamous cell carcinomas (SCC) result from transformation of the epidermal keratinocytes
(KC). They arise from premalignant precursor lesions such as actinic keratoses or squamous
cell carcinoma in situ [1], typically on UV exposed skin [2] or in the case of SCC of the cervix
as a result of infection with high-risk human papillomavirus types. HPV type 16 E7 is a cell
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cycle deregulating protein that contributes to the oncogenesis of HPV16, a high-risk type that
is primarily associated with cervical cancer. Expression of HPV16 E7 in the keratinocytes (KC)
of the epidermis is sufficient to regulate KC cell growth and differentiation [3]. E7-expressing
transgenic mouse skin (K14E7) displays the hallmark characteristics of premalignant skin (hy-
perplasia and hyperkeratosis), contains chronic inflammatory infiltrates that parallel those of
epithelial cancers in humans [4], and SCC develops in these mice late in life [5]. Additionally,
the skin of the K14E7 mouse is immune suppressed and is not rejected when transplanted onto
immune competent mice that should recognise the E7 as a foreign antigen [6]. The K14E7
mouse therefore has utility in understanding regulation of immunity in hyperplastic, premalig-
nant skin.
Langerhans cells (LC) are langerin (CD207) positive dendritic cells that form a network
amongst the KC of the epidermis. They are professional antigen presenting cells (APC), consti-
tutively expressing MHCII and CD11c. In their immature state, LC are competent to take up
and process antigen [7]. Following migration from the epidermis, LC express high levels of
MHCII and costimulatory markers and are potent stimulators of T cells in vitro [8]. A role for
LC in T cell maintenance in the periphery is also now recognized, such that LC induce prolifer-
ation of skin resident T cells in an antigen specific manner [9].
LC are implicated in the immune regulation of T cells in the skin. LC contribute to mainte-
nance of grafts, supporting T cell-mediated suppression [10]. In contrast, at least in the LC-de-
pletable Langerin-DTR transgenic mouse, LC are mediators of chronic hypersensitivity (CHS)
responses, and CHS is suppressed when LC are depleted [11]. The capacity of LC to regulate
the expansion of effector and regulatory skin resident T cells is dependent on the skin microen-
vironment [9]. The effects of the microenvironment on LC in hyperplasia are largely unknown.
The purpose of this study is to establish if LC number and function is affected in the skin of
the K14E7 mouse, to better understand how they are regulated and if they may contribute to
regulation of immunity in premalignant skin. In this study we found that LC were increased in
number and their migration was impaired in E7-expressing epidermis. The LC were activated
and antigen uptake was impaired. However when matured ex vivo, LC from the K14E7 mouse
epidermis were competent to present and cross-present antigen and to prime T cells. These
cells therefore display an atypical, altered phenotype and function when resident in the K14E7
hyperplastic skin. That these cells are competent to present and cross-present following matu-
ration ex vivo suggests signaling from the local microenvironment is required for maintenance
of the altered phenotype in the K14E7 epidermis.
Materials and Methods
Animals
Female C57BL/6, K14E7 (H-2b), RagKO and RagOTI mice aged between 6 and 10 weeks were
obtained from the Animal Resources Centre (Perth, Australia). OTII mice were obtained from
the Walter and Eliza Hall Institute (Melbourne, Australia). K14E7.RagKO mice were generated
by crossing male K14 mice with female RagKO mice. Mice were humanely euthanized by CO2
asphyxiation. Experiments were performed in compliance with the ethical guidelines of the Na-
tional Health and Medical Research Council of Australia, with approval from the University of
Queensland Animal Ethics Committee.
Antibodies
The following antibodies to mouse antigens were used: phycoerythrin (PE) anti-CD45.2
(104; eBioscience), phycoerythrin-indotricarbocyanine (PE-Cy7) anti-CD11c (HL3; BD
Bioscience); anti-MHC class II (I-A/I-E) (M5/114.15.2; eBioscience); anti mouse-CD86 (clone
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GL-1; Biolegend), anti-CD80 (16-10A1, Biolegend); FITC anti-CD40 (HM40-3; BD Biosci-
ence) and Alexa-546 anti-CD207 (929F3.01, Dendritics). Isotype-matched control antibodies
were obtained from BD Biosciences. Flow count fluorospheres (Beckman Coulter) were used
to determine absolute cell counts.
Cell isolation
Ears were separated with forceps into dorsal and ventral halves. Epidermal cells were isolated
by trypsinisation of epidermal sheets following a protocol modified from Koch [12]. The sepa-
rated ear skin was floated dermis-side down on 0.5% trypsin in PBS for 25–45 min. at 37°C.
Epidermis was separated from the dermis and incubated for 30 min at 37°C in Iscove’s medium
containing 10% heat-inactivated fetal calf serum (FCS). The cells in suspension were filtered
through a 70 μm cell strainer and pelleted by centrifugation (400 x g for 4 minutes at 4°C).
For the preparation of lymph node cell suspensions, inguinal lymph nodes were removed
and digested with collagenase D (Roche) for 25 min at 37°C in RPMI-1640 containing 2% heat
inactivated-FCS, followed by incubation with 0.01M EDTA for 5 min. The digested cells were
filtered through cell strainers and washed thoroughly in PBS-EDTA-FCS.
Preparation of tissues for immunofluorescence staining
To prepare epidermal sheets ears were split and floated dermal side down on 0.5 M ammonium
thiocyanate (Sigma-Aldrich, A7149) for 20 min at 37°C [13]. Epidermis was peeled from the
dermal layer and fixed in acetone for 10 min at RT. To prepare frozen tissue, ear skin was em-
bedded in OCT (Sakura Finetek), snap frozen at -20°C and sectioned at 5–8 μm thickness. Sec-
tions were fixed in acetone at RT for 10 min prior to staining.
Antigen uptake assay
To measure antigen uptake, epidermal cell suspensions (3 x 106 cells in 1ml) were incubated
with OVA labeled with 0.1 mg/ml Alexa-555 (Invitrogen) overnight at 37°C. Cells were har-
vested, stained and uptake of OVA-555 by the CD45.2, MHCII, CD207+ cells was measured
using flow cytometry. For confocal analysis CD207+/MHCII+ cells were sorted, fixed with 4%
formalin and cytospun onto glass slides prior to confocal microscopy.
Langerhans cell migration
To measure migration, mouse skin was painted on a 15 mm2 area of shaved abdomen with
5mg/ml FITC in acetone and dibutylphtalate (1:1) 48 h prior to harvest of the inguinal lymph
nodes. Single cell suspensions were prepared and the number of FITC positive Langerhans
cells was determined.
Ex vivo T cell proliferation assay
To test if LC from K14E7 mice could be matured ex vivo, cells were cultured for 72 h in the
presence of 2ng/ml GM-CSF-supplemented media. To test presentation and cross-presentation
of OVA epidermal cell suspensions were incubated with OVA overnight, washed extensively,
cultured for a further 48 h in 2ng/ml GM-CSF-supplemented media then purified to 70–80%
purity using anti-MHCII magnetic cell separation. Purified cells were co-cultured with purified
OT-I or OT-II cells at ratios ranging from 0:1 to 1000:1 for 60 h and T cell proliferation was
measured by incorporation of 3H-thymidine during a further 16 h incubation.
To test the ability of LC to prime T cells, epidermal cell suspensions were incubated with
GM-CSF for 72 h, purified, incubated with the MHCI-restricted OVA peptide SIINFEKL or
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the MHCII-restricted OVA peptide ISQAVHAAHAEINEAGR for 2 h, washed then co-cul-
tured with purified OTI or OTII cells for 72 h. 3H-thymidine was added for an additional 16 h
and incorporation measured.
Flow cytometry
Cell suspensions were resuspended in PBS containing 1% FCS and 0.1% sodium azide and in-
cubated for 15 min at RT with the appropriate antibodies or isotype controls. For CD207 stain-
ing, cells were fixed and permeabilised using the Cytofix/cytoperm (BD BioSciences) according
to the manufacturer’s recommendations. Following treatment, cells were stained with anti-
mouse CD207 for 30 min at RT. Flow cytometric analysis was performed using the FACSCanto
(BD Biosciences).
Immunofluorescence staining
Fixed epidermal sheets (placed on glass slides), or frozen sections, were washed once in PBS be-
fore treated with PBS containing 2.5% FCS (blocking buffer) for 15 min at RT. Tissue were sub-
sequently incubated with anti-CD207 or an isotype-matched control for 1 h at 37°C. After
washing, tissues were mounted with Slowfade Gold (Invitrogen) and images were acquired
using an LSM510 confocal microscope (Zeiss).
Statistical Analysis
Pair-wise comparisons were carried out using Mann-Whitney U test with Prism (GraphPad)
software. Analysis of lymphoproliferation assays was carried out using 2-way analysis of vari-
ance (ANOVA). Error bars on graphs represent standard error of the mean. P> 0.05 is not sig-
nificant (ns); P< 0.05;  P< 0.01,  P< 0.001.
Results
Number and morphology of LC from normal and E7-expressing
epidermis
It has previously been reported that more LC are present in high-grade cervical intraepithelial
lesions, where expression of the HPV oncoproteins is typically increased [14, 15]. A thorough
analysis of the number of LC in E7-expressing epidermis was carried out. Epithelium from
K14E7 and control mice was sectioned then stained with the CD207/langerin-specific anti-
body. Compared with normal epidermis (Fig 1A), the epidermis of the K14E7 mouse displayed
characteristic hyperplasia (Fig 1B), and the LC were located throughout the thickened epider-
mis. In order to determine if the number of LC in the epidermis was affected by E7 expression
in basal keratinocytes, epidermal cells were isolated from K14E7 and C57Bl/6 mice and LC
were enumerated using flow cytometry. The absolute number of LC harvested from K14E7
mouse ear skin was more than twice that of the equivalent C57BL/6 ear skin (Fig 1C). In con-
trast, the proportion of LC relative to KC was reduced in the K14E7 mouse skin when com-
pared to control skin (Fig 1D), reflecting the increased number of KC as a consequence of the
epidermal hyperproliferation caused by E7. Immunofluorescence staining with CD207 and
confocal microscopy was carried out on epidermal sheets to identify LC and to visually validate
the enumeration data. Consistent with the flow cytometry data, there was a greater density of
LC in the epidermis from K14E7 mouse skin (Fig 1E), although overall the distribution was
less uniform. The characteristic dendritic processes that are readily identifiable on the LC in
the epidermis of the C57BL/6 mice were significantly less frequent on LC in K14E7 skin (Fig
1F). Taken together, the increased number of LC, the decreased ratio of LC to KC and their
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more rounded appearance, consistent with activated LC, support altered regulation of LC ho-
meostasis and phenotype in K14E7 skin.
Antigen uptake by LC from normal and K14E7 epidermis
We went on to examine if LC function was altered in K14E7 skin. To investigate whether
endocytic uptake of a soluble protein antigen was affected in LC from K14E7 skin, epidermal
cell suspensions from C57Bl/6 and K14E7 mouse skin were cultured overnight with
Fig 1. The absolute number of LC is increased in K14E7mouse epidermis. Sections of C57Bl/6 (A) and
K14E7 (B) mouse ear were stained with CD207 and imaged by epifluorescence microscopy. The epidermis
(top) is indicated by a broad dashed line, and the epidermis/dermis interface by a narrow dashed line; scale
bar = 50μm. LC (CD45.2, CD11c, CD207, MHCII+) harvested from a 5.5 mm diameter sample of dorsal ear
epidermis were enumerated, with counting beads, by flow cytometry. The absolute number (C) and the
percentage of LC (D) are shown. Confocal imaging was carried out on CD207-stained sheets of dorsal ear
skin (E). Scale bar represents 20μm. Dendrites on the CD207+ LC were enumerated following confocal
imaging (F). **P < 0.01 (Mann-Whitney U test).
doi:10.1371/journal.pone.0127155.g001
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fluorescently-labeled ovalbumin (OVA), harvested, immuno-labeled with CD45, MHCII and
CD207 to identify the LC, and analysed by flow cytometry (Fig 2A). Around half of the LC
from the K14E7 mouse epidermal cultures were OVA positive compared with the C57Bl/6 LC,
and there was a modest but significant overall reduction of OVA fluorescence in the OVA posi-
tive LC from the K14E7 (Fig 2B and 2C). Using confocal microscopy it was confirmed that the
OVA taken into the cell was cytoplasmic and was in a staining pattern consistent with localiza-
tion to endosomes (Fig 2D). Interestingly, OVA appeared to be colocalised with langerin in LC
from C57Bl/6 mice, whereas the distribution of langerin was punctate throughout the cell and
did not co-localise in the LC from the K14E7 mice. Overall, these data show that when cultured
with antigen fewer LC from the K14E7 skin took up the antigen, and those LC took up less an-
tigen than LC from control skin.
LCmigration to the lymph node in the normal and K14E7 mouse
The increased numbers of LC in the K14E7 epidermis may be a result of an inability of the LC
to migrate from the epidermis, leading to their accumulation. To assess the migratory ability of
the K14E7 LC, mouse skin was painted with the contact sensitizer fluorescein isothiocyanate
(FITC), and the absolute number of fluorescent migrating LC was counted. The percentage of
LC that migrated to the LN in the K14E7 mouse 48 h after FITC painting was around half of
that of the C57BL/6 control mice (Fig 3A and 3B). From this we conclude that migration of LC
from the skin in K14E7 mice was impaired compared with control skin, at 48h post activation.
Costimulatory molecule expression on LC from normal and K14E7 skin
T cell activation follows engagement of the TCR with MHC I or MHC II, and engagement of
co-stimulation markers that include CD40, CD80 and CD86 on the antigen presenting cell. We
questioned if expression of costimulatory molecules was altered on the LC from the K14E7
mouse epidermis. Epidermal cell suspensions were prepared from K14E7 and control mice and
the expression of CD40, CD80 and CD86 on the LC was measured. Expression of each of the
co-stimulatory markers tested here was somewhat increased on LC extracted from K14E7
mouse epidermis, compared to LC from control mice (Fig 4). Thus the LC from the K14E7 hy-
perplastic skin costimulatory molecule expression was consistent with partial activation.
Molecular crosstalk from T cells can alter the phenotype of dendritic cells, including co-
stimulatory molecule expression [16]. To test the requirement for functional T lymphocytes in
the increased surface molecule expression that we observed on LC from the K14E7 mouse skin,
these mice were crossed with RagKO mice. The increased expression of CD40, CD80 and
CD86 that we observed in the K14E7 mice was also detected in the K14E7xRagKO mice, in the
absence of functional T cells (Fig 5). Therefore up-regulation of costimulatory molecules on
epidermal LC from the K14E7 mouse is independent of the presence of functional lymphocytes
in the skin.
K14E7 LC capacity to prime T cells compared with LC from normal skin
LC extracted from skin can be induced to mature in vitro in the presence of GM-CSF [17]. We
found that LC from K14E7 mice expressed significantly higher levels of CD40, CD80 and
CD86 on the cell surface following culture for 72 h in the presence of GM-CSF, compared with
LC obtained directly from the epidermis and stained (Fig 6A). When compared with cultured
control cells, there was some variability in levels of expression of each of the markers on K14E7
cells, with no significant difference (M-W) in CD80 expression, reduced CD40 expression
(M-W; P< 0.01) and increased CD86 expression (M-W; P< 0.05). However overall, co-stimu-
latory marker expression was significantly increased on cells from either the K14E7 or the
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Fig 2. Antigen uptake is reduced in K14E7mice. Epidermal cell suspensions from C57BL/6 and K14E7
mice were cultured with Alexa-555-labelled OVA overnight at 37°C, stained and analysed by flow cytometry
(A). The Alexa-555-OVA+ LC (CD45.2+, MHC Class II+, CD207+) as a percentage of total LC (B) and the
level of expression of Alexa-555-OVA on the positive stained LC is shown (C). **P < 0.01; *P < 0.05 (Mann-
Whitney U test). Confocal imaging of CD207+, MHCII+ LC that have taken up Alexa-555-OVA (D).
doi:10.1371/journal.pone.0127155.g002
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control mouse skin when compared to fresh cells, indicating cell maturation in culture had
occurred.
The ability of LC from K14E7 skin to present and cross-present antigen to prime T cells was
measured. Epidermal cell suspensions from K14E7 or control mice were pulsed with OVA and
matured by culture in GM-CSF. The matured LC were purified, co-cultured with OT-I or
OT-II cells, and T cell proliferation measured. There was no difference in the ability of matured
LC from the K14E7 mouse to cross-present OVA to OTI cells or to present OVA to OTII cells
(Fig 6B). The ability of the matured LC to prime T cells following incubation with SIINFEKL
or ISQAVHAAHAEINEAGR was also tested. There was no difference in the ability of the ma-
tured LC to prime OT-I or OT-II cells ex vivo (Fig 6C).
Discussion
Our data show that LC number and phenotype is altered in the hyperplastic, chronic inflam-
matory epidermis of the K14E7 mouse. Although several studies have reported that LC
numbers are reduced in HPV16-infected low-grade cervical tissue [18], LC are increased in
high-grade cervical intraepithelial neoplasia [14, 15]. Key differences in high-grade lesions that
may contribute to regulation of LC number include increased expression of HPV oncoproteins
and the resultant hyperproliferation and chronic inflammation. In support of this, increased
LC are associated with chronic inflammatory conditions in humans, for example lichen planus
[19], where they are proposed to have a role in the pathogenesis of the disease [20]. We propose
Fig 3. LCmigration from the epidermis is reduced the in K14E7mice.C57Bl/6 and K14E7 mice were painted with FITC on a 15mm2 area of abdomen
and inguinal lymph nodes harvested 48 h later. Single cell suspensions were stained with CD11c, MHC class II and CD207 (A). The absolute number of FITC
positive cells was determined (B). The total migrated LC in the lymph nodes as a percentage of the mean total number of LC in the painted skin is shown (C).
*P < 0.05 (Mann-Whitney U test).
doi:10.1371/journal.pone.0127155.g003
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that the secondary effects of E7 on the epidermis, including hyperplasia and chronic inflamma-
tion, contribute to the increased number of LC found there.
There was a pronounced difference in the morphology on the LC in the K14E7 mouse skin.
Cells were more rounded and less dendritic, when compared with the control cells. Resting LC
regularly extend and retract their dendrites between KC [21] however dendritic processes elon-
gate when LC sense pro-inflammatory signals [22]. The retracted dendrites of LC from K14E7
epidermis may indicate differences in LC regulation between proinflammatory epidermis and
the chronically inflamed, hyperproliferative K14E7 epidermis, where only selected proinflam-
matory cytokines are expressed [23]. Additionally, Cdc42 is a Rho-family GTPase that may be
implicated in the LC phenotype we observe here. LC in Cdc42-deficient epidermis are less den-
dritic and display a rounded phenotype, consistent with what we observe here, and do not mi-
grate to the lymph node following activation [24].
Although we have not established if the kinetics of LC migration was altered, we did find
that emigration of LC from the K14E7 hyperplastic epidermis is reduced at 48h post activation,
Fig 4. Co-stimulatory molecules are upregulated on epidermal LC from K14E7mice. Epidermal
suspensions were prepared from K14E7 and control mice and stained with antibodies to CD45.2, CD11c,
CD207 to identify LC and CD40, CD80 and CD86 to determine their levels of expression. Expression of
CD40, CD80 and CD86 (dark line) and isotype staining (light blue line) on LC is shown for representative flow
cytometry data (A) and graphically for all data (B). ***P < 0.001; **P < 0.01; *P < 0.05 (Mann-Whitney U
test).
doi:10.1371/journal.pone.0127155.g004
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which may contribute to an accumulation of LC in the skin. This may seem surprising as ex-
pression of IL-1β, TNF-α and IL-18, cytokines associated with migration of LC from the skin,
are all increased in K14E7 epidermis [25, 26]. However high levels of TNF-α inhibit LC migra-
tion [27] and IL-10, which is also inhibitory [28], is significantly increased in E7-expressing
epidermis [26]. Regulation of cytokine expression in E7-expressing KC is therefore a likely con-
tributor to the inhibition of LC emigration that we observed here.
The increase in LC may also result from an influx of LC precursors into the skin. During tis-
sue trauma and acute inflammation, LC are repopulated by circulating Gr1hi blood monocytes
that differentiate into LC in the epidermis [29, 30]. LC immigration is mainly controlled by in-
creased expression by KC of the chemoattractant MIP3α/CCL20 [31]. We see increased levels
of CCL20 RNA (manuscript in preparation) in K14E7 mouse skin, suggesting that this may be
the case.
Fig 5. Increased expression of costimulatory molecules by E7 occurs in the absence of functional
lymphocytes. Epidermal cell suspensions prepared from RagKO and K14.RagKOmice were stained with
antibodies to CD45.2, CD11c, CD207 to identify LC and CD40, CD80 and CD86 to determine their levels of
expression. Expression of CD40, CD80 and CD86 (dark line) and isotype staining (light blue line) on LC is
shown for representative flow cytometry data (A) and graphically for all data (B). **P < 0.01 (Mann-Whitney U
test).
doi:10.1371/journal.pone.0127155.g005
Langerhans Cell Regulation in Hyperplasia
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Proliferation of LC resident in the epidermis is essential for LC homeostasis [32], but may
also contribute to increased LC numbers in the hyperproliferative epidermis in the K14E7
mouse. Induction of atopic dermatitis in the mouse results in epidermal proliferation, causing
skin thickening and inflammation and an increase in LC numbers. There was strong local pro-
liferation of LC that was attributed to unidentified factor or factors produced by the hyperproli-
ferative keratinocytes [33]. It is feasible that secretion of one or more LC proliferation-
inducing factors produced by the E7-expressing, hyperplastic KC has a growth effect on LC in
the local microenvironment that may also contribute to LC expansion in the K14E7 mouse
epidermis.
Expression of CD40, CD80 and CD86 were increased on LC in the K14E7 epidermis. Ex-
pression of co-stimulatory molecules, including CD80 and CD86, is increased on mature LC,
and normally occurs during migration of LC to the lymph nodes [34–36]. However increased
CD80 and CD86 are observed in chronically inflamed skin conditions, such as atopic dermati-
tis [37]. Mechanistically, HPV16 E7 increases NFκB activity in KC to induce expression of se-
lected proinflammatory cytokines [23], which may account for the increased CD80 and CD86
expression on the neighbouring LC. In addition, iNKT cells infiltrate K14E7 mouse skin [38].
These cells regulate IFNγ [38], which induces CD80 and CD86 expression on APC [39]. IFNγ
produced by lymphocytes may contribute to increased CD80 and CD86 but does not appear to
be of primary importance mechanistically as expression of these molecules was also increased
on LC from K14E7xRag-/- mice, in the absence of functional lymphocytes.
The K14E7-derived LC displayed impaired antigen uptake that when cultured with OVA-
555. OVA uptake is mediated by macropinocytosis [40] and clathrin-mediated endocytosis via
C-type lectins [41]. Also langerin contains EPN-motif shared by the C-type lectins in the
mouse DC-sign family and can mediate uptake of glycosylated proteins such as OVA [42]. The
co-localisation of langerin with OVA in LC from the C57Bl/6 mice that we observed supports
its involvement in the uptake of OVA. Interestingly, langerin association with OVA taken up
by LC has been shown in immature LC, whereas although mature LC are readily able to take
up OVA, it does not colocalise with langerin in the LC [43]. Consistent with this, although lan-
gerin expression was not altered in the K14E7 LC (data not shown), OVA and langerin were
not co-localised. Sparber, et al. (2010) suggested that different uptake pathways were used at
different stages of LC maturation. Indeed this may be the case, as the LC from the K14E7 skin
expressed increased CD40, CD80 and CD86, consistent with a more mature state. Upregula-
tion of CD40, CD80 and CD86 on LC is typical of a state of activation, for example following
hapten painting [17, 44]. The increased expression of co-stimulatory markers indicates that
cells are somewhat activated in the chronic inflammatory and hyperproliferative K14E7
epidermis.
The LC from C57Bl/6 skin were efficient cross-presenters of exogenous antigen, as has been
reported previously [45]. We were surprised to see that LC extracted from K14E7 and control
skin and matured following culture with GM-CSF did not differ in their capacity to present or
cross-present antigen to T cells in vitro. Although the phenotype of the LC from the K14E7
mouse was substantially altered when resident in the skin, these cells retained the capacity to
Fig 6. Co-stimulatory molecule expression is increased, and presentation and cross-presentation by LC from K14E7mice does not differ from LC
from C57Bl/6 mice. Expression of CD40, CD80 and CD86 was compared on CD45.2, CD11c, CD207 positive LC from C57Bl/6 and K14E7mice prepared
either directly from epidermal suspensions (fresh) or from epidermal cells that were matured in culture for 72 h in medium containing GM-CSF (A). Epidermal
cells from C57BL/6 and K14E7mice were incubated with OVA, cultured for 2 days then LC purified and co-cultured with purified OT-I or OT-II cells for 60 h. T
cell proliferation was measured after addition 3H-thymidine for a further 16h (B). Epidermal cells were cultured for 72 h in GM-CSF, LC purified and pulsed
with SIINFEKL or ISQAVHAAHAEINEAGR for 2 h, washed and co-cultured with T cells for 60 h. T cell proliferation was measured after addition 3H-thymidine
for a further 16h (C). Data was analysed using 2-way ANOVA and there was no significant difference between the groups.
doi:10.1371/journal.pone.0127155.g006
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be further matured and to present and cross-present antigen. From this we conclude that the
altered phenotype of the LC from the K14E7 mice is regulated by the skin microenvironment
but is reversible when cells are removed from the skin and matured ex vivo.
Here we show that LC in hyperplastic E7-expressing skin are increased in frequency and are
partially activated either as a direct consequence of E7 expression or as a result of the effects of
E7 on the skin microenvironment. These cells are held in a state where if harvested and tested
directly for antigen uptake, their ability to do so is impaired. Additionally, their migration to
the lymph nodes is impaired in vivo. However when the LC are removed from the skin micro-
environment and further differentiated in culture, their competence to present antigen and
provide co-stimulatory signals to T cells is intact. This suggests that the functional regulation
of LC from E7-expressing skin is local, dependent on the E7-skin microenvironment, but also
may be reversible. We therefore speculate that the function of LC from E7 may be restored
using immune modifying strategies, which could be applied for therapeutic benefit against
HPV infection in the event that LC do contribute to the immune suppression seen in K14E7
mouse skin.
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